NOLC1, an enhancer of nasopharyngeal carcinoma progression, is essential for TP53 to regulate MDM2 expression

American Journal of Pathology

Volumn 175, Issue 1, 2009, Pages 342-354

  Hwang, Yu Chyi ^a   Lu, Tung Ying ^a   Huang, Dah Yeou ^a   Kuo, Yuan Sung ^b   Kao, Cheng Fu ^c   Yeh, Ning Hsing ^d   Wu, Han Chung ^a,c   Lin, Chin Tarng ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c INSTITUTE OF CELLULAR AND ORGANISMIC BIOLOGY   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TUBULIN; BETA ACTIN; GENE PRODUCT; PROTEIN MDM2; PROTEIN NOLC1; PROTEIN P53; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL GROWTH; CHINA; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; ENHANCER REGION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MDM2 GENE; MICROARRAY ANALYSIS; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTO ONCOGENE; REGULATORY MECHANISM; SCID MOUSE; SINGAPORE; SUBTRACTIVE HYBRIDIZATION; TAIWAN; TUMOR CELL; TUMOR GROWTH;

EID: 67649934999     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.080931     Document Type: Article

References (55)

1. WHO International Agency for Research on Cancer: Epstein-Barr virus and Kaposi's sarcoma herpes virus/human herpes virus 8. IARC Monographs on the Evaluation of Carcinogenic Risk to Humans. Lyon, France, IARC, 1997, pp 1-2
2. Lo KW, To KF, Huang DP: Focus on nasopharyngeal carcinoma. Cancer Cell 2004, 5:423-428
3. Yu MC, Huang TB, Henderson BE: Diet and nasopharyngeal carcinoma: a case-control study in Guangzhou China. Int J Cancer 1989, 43:1077-1082
4. Geser A, Charnay N, Day NE, de-The G, Ho HC: Environmental factors in the etiology of nasopharyngeal carcinoma: report on a case-control study in Hong Kong. IARC Sci Publ 1978, 213-229
5. Armstrong RW, Armstrong MJ, Yu MC, Henderson BE: Salted fish and inhalants as risk factors for nasopharyngeal carcinoma in Malaysian Chinese. Cancer Res 1983, 43:2967-2970
6. Ho CK, Lo WC, Huang PH, Wu MT, Christiani DC, Lin CT: Suspected nasopharyngeal carcinoma in three workers with long-term exposure to sulphuric acid vapour. Occup Environ Med 1999, 56:426-428
7. Liu YH, Du CL, Lin CT, Chan CC, Chen CJ, Wang JD: Increased morbidity from nasopharyngeal carcinoma and chronic pharyngitis or sinusitis among workers at a newspaper printing company. Occup Environ Med 2002, 59:18-22
8. Jia WH, Collins A, Zeng YX, Feng BJ, Yu XJ, Huang LX, Feng QS, Huang P, Yao MH, Shugart YY: Complex segregation analysis of nasopharyngeal carcinoma in Guangdong China: evidence for a multifactorial mode of inheritance (complex segregation analysis of NPC in China). Eur J Hum Genet 2005, 13:248-252
9. Young LS, Rickinson AB: Epstein-Barr virus: 40 years on. Nat Rev Cancer 2004, 4:757-768
10. Raab-Traub N, Flynn K: The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 1986, 47:883-889
11. Rickinson A, Kieff E: Epstein-Barr virus. Fields Virology. Edited by Field BN, Knipe DM, Howley PM. Philadelphia, Lippincott-Raven, 1996, pp 2397-2446
12. Niedobitek G, Hansmann ML, Herbst H, Young LS, Dienemann D, Hartmann CA, Finn T, Pitteroff S, Welt A, Anagnostopoulos I, Friedrich R, Lobeck H, Sam CK, Araujo I, Rickinson AB, Stein H: Epstein-Barr virus and carcinomas: undifferentiated carcinomas but not squamous cell carcinomas of the nasopharynx are regularly associated with the virus. J Pathol 1991, 165: 17-24
13. Lin CT, Lin CR, Tan GK, Chen W, Dee AN, Chan WY: The mechanism of Epstein-Barr virus infection in nasopharyngeal carcinoma cells. Am J Pathol 1997, 150:1745-1756
14. zur Hausen H, Schulte-Holthausen H, Klein G, Henle W, Henle G, Clifford P, Santesson L: EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature 1970, 228:1056-1058
15. Helen G, Helen W: Seroepidemiology of the virus. Epstein MA, Achong BG. The Epstein-Barr Virus. Berlin, Springer-Verlag, 1979, pp 279-320
16. Klein G: The relationship of the virus to nasopharyngeal carcinoma. Epstein MA, Achong BG. The Epstein-Barr Virus. Berlin, Springer-Verlag, 1979, pp 239-350
17. Lee YC, Hwang YC, Chen KC, Lin YS, Huang DY, Huang TW, Kao CY, Wu HC, Lin CT, Huang CY: Effect of Epstein-Barr virus infection on global gene expression in nasopharyngeal carcinoma. Funct Integr Genomics 2007, 7:79-93
18. Lin CT: Epstein-Barr virus: new research in epithelial carcinoma. New Development in Epstein-Barr Virus Research. Edited by CS Umar. New York, Nova Science Publishers, 2006, pp 79-93
19. Diatchenko L, Lau YF, Campbell AP, Chenchik A, Moqadam F, Huang B, Lukyanov S, Lukyanov K, Gurskaya N, Sverdlov ED, Siebert PD: Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci USA 1996, 93:6025-6030
20. Burgos JS: Involvement of the Epstein-Barr virus in the nasopharyngeal carcinoma pathogenesis. Med Oncol 2005, 22:113-121
21. Chen MK, Lee HS, Chang JH, Chang CC: Expression of p53 protein and primary tumour volume in patients with nasopharyngeal carcinoma. J Otolaryngol 2004, 33:304-307
22. Niemhom S, Kitazawa S, Murao S, Kunachak S, Maeda S: Co-expression of p53 and bcl-2 may correlate to the presence of epstein-barr virus genome and the expression of proliferating cell nuclear antigen in nasopharyngeal carcinoma. Cancer Lett 2000, 160:199-208
23. Fan SQ, Ma J, Zhou J, Xiong W, Xiao BY, Zhang WL, Tan C, Li XL, Shen SR, Zhou M, Zhang QH, Ou YJ, Zhuo HD, Fan S, Zhou YH, Li GY: Differential expression of Epstein-Barr virus-encoded RNA and several tumor-related genes in various types of nasopharyngeal epithelial lesions and nasopharyngeal carcinoma using tissue microarray analysis. Hum Pathol 2006, 37:593-605
24. Meier UT, Blobel G: Nopp140 shuttles on tracks between nucleolus and cytoplasm. Cell 1992, 70:127-138
25. Miau LH, Chang CJ, Tsai WH, Lee SC: Identification and characterization of a nucleolar phosphoprotein. Nopp140, as a transcription factor Mol Cell Biol 1997, 17:230-239
26. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B: Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 1992, 358:80-83
27. Barak Y, Gottlieb E, Juven-Gershon T, Oren M: Regulation of mdm2 expression by p53: alternative promoters produce transcripts with nonidentical translation potential. Genes Dev 1994, 8:1739-1749
28. Zauberman A, Flusberg D, Haupt Y, Barak Y, Oren M: A functional p53-responsive intronic promoter is contained within the human mdm2 gene. Nucleic Acids Res 1995, 23:2584-2592
29. Wu HC, Lin YJ, Lee JJ, Liu YJ, Liang ST, Peng Y, Chiu YW, Wu CW, Lin CT: Functional analysis of EBV in nasopharyngeal carcinoma cells. Lab Invest 2003, 83:797-812
30. Lin CT, Wong CI, Chan WY, Tzung KW, Ho JK, Hsu MM, Chuang SM: Establishment and characterization of two nasopharyngeal carcinoma cell lines. Lab Invest 1990, 62:713-724
31. Lin CT, Chan WY, Chen W, Huang HM, Wu HC, Hsu MM, Chuang SM, Wang CC: Characterization of seven newly established nasopharyngeal carcinoma cell lines. Lab Invest 1993, 68:716-727
32. Liao SK, Perng YP, Shen YC, Chung PJ, Chang YS, Wang CH: Chromosomal abnormalities of a new nasopharyngeal carcinoma cell line (NPC-BM1) derived from a bone marrow metastatic lesion. Cancer Genet Cytogenet 1998, 103:52-58
33. Chinese Academy of Medical Sciences, Chungshan Medical College: Establishment of an epithelial cell line and fusiform cell line from a patient with nasopharyngeal carcinoma (in Chinese). Sci Sin 1978, 21: 113-118
34. Gu SY, Tang WP, Zeng Y, Zhao ML, Zhao EWP, Deng WH, Li K: An epithelial cell line established from poorly differentiated nasopharyngeal carcinoma (in Chinese). Chin J Cancer 1983, 2:70-72
35. Hwang JK, Lin CT: Co-localization of endogenous and exogenous p53 proteins in nasopharyngeal carcinoma cells. J Histochem Cytochem 1997, 45:991-1003
36. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, New York, Cold Spring Harbor Laboratory, 1989, pp 11.38-11.98
37. Don RH, Cox PT, Wainwright BJ, Baker K, Mattick JS: 'Touchdown' PCR to circumvent spurious priming during gene amplification. Nucleic Acids Res 1991, 19:4008
38. Pai CY, Chen HK, Sheu HL, Yeh NH: Cell-cycle-dependent alterations of a highly phosphorylated nucleolar protein p130 are associated with nucleologenesis. J Cell Sci 1995, 108:1911-1920
39. Wu HC, Lin CT: Association of heterotrimeric GTP binding regulatory protein (Go) with mitosis. Lab Invest 1994, 71:175-181
40. Sixbey JW, Yao QY: Immunoglobulin A-induced shift of Epstein-Barr virus tissue tropism. Science 1992, 255:1578-1580
41. Singhal S, Vachani A, ntin-Ozerkis D, Kaiser LR, Albelda SM: Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: a review. Clin Cancer Res 2005, 11:3974-3986
42. Huang DY, Lin YT, Jan PS, Hwang YC, Liang ST, Peng Y, Huang CY, Wu HC, Lin CT: Transcription factor SOX-5 enhances nasopharyngeal carcinoma progression by down-regulating SPARC gene expression. J Pathol 2008, 214:445-455
43. Barak Y, Juven T, Haffner R, Oren M: mdm2 expression is induced by wild type p53 activity. EMBO J 1993, 12:461-468
44. Wu HC, Lu TY, Lee JJ, Hwang JK, Lin YJ, Wang CK, Lin CT: MDM2 expression in EBV-infected nasopharyngeal carcinoma cells. Lab Invest 2004, 84:1547-1556
45. Chou J, Lin YC, Kim J, You L, Xu Z, He B, Jablons DM: Nasopharyngeal carcinoma-review of the molecular mechanisms of tumorigenesis. Head Neck 2008, 30:946-963
46. Wei CL, Wu Q, Vega VB, Chiu KP, Ng P, Zhang T, Shahab A, Yong HC, Fu Y, Weng Z, Liu J, Zhao XD, Chew JL, Lee YL, Kuznetsov VA, Sung WK, Miller LD, Lim B, Liu ET, Yu Q, Ng HH, Ruan Y: A global map of p53 transcription-factor binding sites in the human genome. Cell 2006, 124:207-219
47. Lo SJ, Lee CC, Lai HJ: The nucleolus: reviewing oldies to have new understandings. Cell Res 2006, 16:530-538
48. Bouwmeester T, Bauch A, Ruffner H, Angrand PO, Bergamini G, Croughton K, Cruciat C, Eberhard D, Gagneur J, Ghidelli S, Hopf C, Huhse B, Mangano R, Michon AM, Schirle M, Schlegl J, Schwab M, Stein MA, Bauer A, Casari G, Drewes G, Gavin AC, Jackson DB, Joberty G, Neubauer G, Rick J, Kuster B, Superti-Furga G: A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway. Nat Cell Biol 2004, 6:97-105
49. Kelliher MA, Grimm S, Ishida Y, Kuo F, Stanger BZ, Leder P: The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity 1998, 8:297-303
50. Lacroix M, Toillon RA, Leclercq G: p53 and breast cancer, an update. Endocr Relat Cancer 2006, 13:293-325
51. Sheu LF, Chen A, Lee HS, Hsu HY, Yu DS: Cooperative interactions among p53, bcl-2 and Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma cells. Pathol Int 2004, 54:475-485
52. Lowe SW, Sherr CJ: Tumor suppression by Ink4a-Arf: progress and puzzles. Curr Opin Genet Dev 2003, 13:77-83
53. Tao W, Levine AJ: P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2. Proc Natl Acad Sci USA 1999, 96:6937-6941
54. Weber JD, Taylor LJ, Roussel MF, Sherr CJ, Bar-Sagi D: Nucleolar Arf sequesters Mdm2 and activates p53. Nat Cell Biol 1999, 1:20-26
55. Makitie AA, MacMillan C, Ho J, Shi W, Lee A, O'Sullivan B, Payne D, Pintilie M, Cummings B, Waldron J, Warde P, Irish J, Brown D, Gilbert R, Gullane P, Liu FF, Kamel-Reid S: Loss of p16 expression has prognostic significance in human nasopharyngeal carcinoma. Clin Cancer Res 2003, 9:2177-2184